Two Sigma Investments

Two Sigma Investments’s Ginkgo Bioworks DNA Stock Holding History

Two Sigma Investments’s Portfolio DNA Stock Details DNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$390K	Buy	63,616 +3,256	+5%	+$27.1K	﹤0.01%	3893
2025 Q4	$502K	Sell	60,360 -114,303	-65%	-$1.23M	﹤0.01%	3301
2025 Q3	$2.55M	Sell	174,663 -28,944	-14%	-$346K	﹤0.01%	1968
2025 Q2	$2.29M	Sell	203,607 -110,616	-35%	-$857K	﹤0.01%	1739
2025 Q1	$1.79M	Sell	314,223 -331,139	-51%	-$3.37M	﹤0.01%	1805
2024 Q4	$6.34M	Sell	645,362 -14,069	-2%	-$121K	0.01%	964
2024 Q3	$5.37M	Buy	659,431 +174,166	+36%	+$1.75M	0.01%	1050
2024 Q2	$6.49M	Buy	485,265 +482,436	+17,053%	+$14.4M	0.02%	891
2024 Q1	$131K	Sell	2,829 -2,902	-51%	-$150K	﹤0.01%	2796
2023 Q4	$387K	Sell	5,731 -15,968	-74%	-$978K	﹤0.01%	2584
2023 Q3	$1.57M	Buy	+21,699	New	+$1.73M	﹤0.01%	1610
2023 Q2	–	Sell	-5,600	Closed	-$298K	–	3073
2023 Q1	$298K	Sell	5,600 -46,697	-89%	-$2.96M	﹤0.01%	2423
2022 Q4	$3.54M	Buy	+52,297	New	+$4.81M	0.01%	1031
2022 Q2	–	Sell	-1,452	Closed	-$234K	–	2611
2022 Q1	$234K	Buy	+1,452	New	+$283K	﹤0.01%	2300

Other funds holding DNA

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Viking Global Investors

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Baillie Gifford & Co

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Anchorage Capital Group New York $436M AUM 38.51% 1-Year Est. Return

Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return

Legal & General Group

Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

J.M. Forbes & Co Boston, Massachusetts $1.18B AUM 27.3% 1-Year Est. Return

Geode Capital Management

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return